FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans
Reuters2026/09/13 22:32- FDA cleared Telix’s Pixclara, an F-18 PET imaging drug for glioma, marking the first approved FET-PET agent in the US.
- Label covers adults, pediatric patients from 1 month old, to help distinguish recurrent or progressive glioma from treatment-related changes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Faraday Future adds government procurement veteran Steven Newton as senior strategic advisor
JPMorgan: Tesla (TSLA.US) Robotaxi revenue may reach $320 billions by 2035, with nearly 98% coming from its own fleet
JPMorgan analyst Rajat Gupta released a research report last week, estimating that by 2035, Tesla's Robotaxi revenue will reach approximately $320 billion, with nearly $314 billion coming from Tesla's own and operated fleet, rather than from the owner-operated "Tesla Network."
Charles Hoskinson Says AI Has Destroyed The Old Crypto Growth Metric
Kvika appoints Jón Birgir Jónsson as CEO, effective Dec. 1
Crypto prices
More
